- Aug 9, 2019

New discovery could help doctors identify children at risk for Wilms’ tumor relapse

"Today, researchers from MSK Kids at Memorial Sloan Kettering Cancer Center (MSK) published results that examine elevated levels of a protein called prohibitin in the urine and tumors of children with Wilms' tumors. Their findings could help doctors identify children who are at risk for disease recurrence and precisely tailor treatment to overcome drug resistance."

Developing ‘kinder’ treatments for a devastating childhood cancer

Breakthrough as new drug promises to shield child cancer patients from hearing loss

Study finds higher breast cancer risk after certain forms of childhood cancer treatment

Aggressive Cancer Cells Transformed Into Healthy Cells in Breakthrough

Cardiac RT May Amplify Late Disease Risk in Pediatric Cancer Survivors

Are Cannabis-Based Medicines Safe for Children With Cancer?

Homoharringtonine May be ‘Better Alternative’ to Etoposide In Pediatric AML

Researchers discover new therapeutic approach for neuroblastoma

Solving the Mystery of Long-Lasting Cancer Treatment – Scientists Reveal New Insights

The challenge of treating childhood brain cancers

Recent Posts

New discovery could help doctors identify children at risk for Wilms’ tumor relapse

Archive

Search By Tags